0001493152-25-003248.txt : 20250122 0001493152-25-003248.hdr.sgml : 20250122 20250122170118 ACCESSION NUMBER: 0001493152-25-003248 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20250122 DATE AS OF CHANGE: 20250122 EFFECTIVENESS DATE: 20250122 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Indaptus Therapeutics, Inc. CENTRAL INDEX KEY: 0001857044 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 863158720 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-535974 FILM NUMBER: 25546619 BUSINESS ADDRESS: STREET 1: 3 COLUMBUS CIRCLE STREET 2: 15TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: (646) 427-2727 MAIL ADDRESS: STREET 1: 3 COLUMBUS CIRCLE STREET 2: 15TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: Intec Parent Inc. DATE OF NAME CHANGE: 20210414 D 1 primary_doc.xml X0708 D LIVE 0001857044 Indaptus Therapeutics, Inc. 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY NEW YORK 10019 (646) 427-2727 DELAWARE INTEC PARENT, INC. Intec Parent Inc. Corporation true 2021 JEFFREY A. MECKLER INDAPTUS THERAPEUTICS, INC. 3 COLUMBUS CIRCLE, 15TH FLOOR NEW YORK NY NEW YORK 10019 Executive Officer Director WALT A LINSCOTT INDAPTUS THERAPEUTICS, INC. 3 COLUMBUS CIRCLE, 15TH FLOOR NEW YORK NY NEW YORK 10019 Executive Officer NIR SASSI INDAPTUS THERAPEUTICS, INC. 3 COLUMBUS CIRCLE, 15TH FLOOR NEW YORK NY NEW YORK 10019 Executive Officer MICHAEL J. NEWMAN INDAPTUS THERAPEUTICS, INC. 3 COLUMBUS CIRCLE, 15TH FLOOR NEW YORK NY NEW YORK 10019 Executive Officer Director ROGER WALTZMAN INDAPTUS THERAPEUTICS, INC. 3 COLUMBUS CIRCLE, 15TH FLOOR NEW YORK NY NEW YORK 10019 Executive Officer HILA KARAH INDAPTUS THERAPEUTICS, INC. 3 COLUMBUS CIRCLE, 15TH FLOOR NEW YORK NY NEW YORK 10019 Director ANTHONY J. MADDALUNA INDAPTUS THERAPEUTICS, INC. 3 COLUMBUS CIRCLE, 15TH FLOOR NEW YORK NY NEW YORK 10019 Director WILLIAM B. HAYES INDAPTUS THERAPEUTICS, INC. 3 COLUMBUS CIRCLE, 15TH FLOOR NEW YORK NY NEW YORK 10019 Director ROGER J. POMERANTZ INDAPTUS THERAPEUTICS, INC. 3 COLUMBUS CIRCLE, 15TH FLOOR NEW YORK NY NEW YORK 10019 Director MARK J GILBERT INDAPTUS THERAPEUTICS, INC. 3 COLUMBUS CIRCLE, 15TH FLOOR NEW YORK NY NEW YORK 10019 Director ROBERT E. MARTELL INDAPTUS THERAPEUTICS, INC. 3 COLUMBUS CIRCLE, 15TH FLOOR NEW YORK NY NEW YORK 10019 Director Pharmaceuticals Decline to Disclose 06b false 2025-01-16 false true true true true 2,109,383 shares of Common Stock and common warrants to purchase up to 2,109,383 shares of Common Stock false 0 Paulson Investment Company, LLC 000005670 None None 10220 SW Greenburg Rd Suite 380 Portland OR OREGON 97223 All States false 2246500 2246500 0 Offering of 2,109,383 unregistered shares of Common Stock and unregistered warrants to purchase up to 2,109,383 shares of Common Stock. false 16 157255 true 0 The Issuer paid placement agent 7% of gross proceeds & issued placement agent warrants to purchase up to 147,656 shares (exercise price per share equal to $1.175) & paid a non-accountable sum of $25,000. 0 true false Indaptus Therapeutics, Inc. /s/ Nir Sassi Nir Sassi Chief Financial Officer 2025-01-21